Dejonckheere, C.S.; Torres-Crigna, A.; Layer, J.P.; Layer, K.; Wiegreffe, S.; Sarria, G.R.; Scafa, D.; Koch, D.; Leitzen, C.; Köksal, M.A.;
et al. Non-Invasive Physical Plasma for Preventing Radiation Dermatitis in Breast Cancer: A First-In-Human Feasibility Study. Pharmaceutics 2022, 14, 1767.
https://doi.org/10.3390/pharmaceutics14091767
AMA Style
Dejonckheere CS, Torres-Crigna A, Layer JP, Layer K, Wiegreffe S, Sarria GR, Scafa D, Koch D, Leitzen C, Köksal MA,
et al. Non-Invasive Physical Plasma for Preventing Radiation Dermatitis in Breast Cancer: A First-In-Human Feasibility Study. Pharmaceutics. 2022; 14(9):1767.
https://doi.org/10.3390/pharmaceutics14091767
Chicago/Turabian Style
Dejonckheere, Cas Stefaan, Adriana Torres-Crigna, Julian Philipp Layer, Katharina Layer, Shari Wiegreffe, Gustavo Renato Sarria, Davide Scafa, David Koch, Christina Leitzen, Mümtaz Ali Köksal,
and et al. 2022. "Non-Invasive Physical Plasma for Preventing Radiation Dermatitis in Breast Cancer: A First-In-Human Feasibility Study" Pharmaceutics 14, no. 9: 1767.
https://doi.org/10.3390/pharmaceutics14091767
APA Style
Dejonckheere, C. S., Torres-Crigna, A., Layer, J. P., Layer, K., Wiegreffe, S., Sarria, G. R., Scafa, D., Koch, D., Leitzen, C., Köksal, M. A., Müdder, T., Abramian, A., Kaiser, C., Faridi, A., Stope, M. B., Mustea, A., Giordano, F. A., & Schmeel, L. C.
(2022). Non-Invasive Physical Plasma for Preventing Radiation Dermatitis in Breast Cancer: A First-In-Human Feasibility Study. Pharmaceutics, 14(9), 1767.
https://doi.org/10.3390/pharmaceutics14091767
